Stocks of several companies are expected to remain in the spotlight today following a series of announcements related to international expansion, regulatory approvals, and strategic partnerships.
Zydus Lifesciences announced its entry into France through the acquisition of an orthopedic firm, establishing a new unit in the European market. This marks a significant step in the company’s global footprint expansion.
Aurobindo Pharma received final approval from the USFDA for its generic version of Xarelto (2.5mg), targeting the U.S. market worth $447 million. The approval is expected to boost its revenue from North America.
HCL Technologies said it has added three more Google Cloud specialisations and announced the integration of Nvidia’s AI Enterprise and Omniverse with its own GenAI offerings. The company continues to expand its capabilities in artificial intelligence and cloud services.
Tata Power reported its total renewable energy portfolio has reached 10.9 GW, after signing a Power Purchase Agreement (PPA) with NTPC Limited for a 200 MW firm and dispatchable renewable energy project.
Indian Hotels Company Ltd stated it has signed 74 hotels and opened 26 new properties during FY25, expanding its overall network to 380 hotels. The expansion reflects growing demand in the Indian hospitality sector.
Cyient has secured a strategic contract in Norway to support Green H Bodø in building a hydrogen production and distribution facility in Bodø. This aligns with Cyient’s global sustainability-focused solutions strategy.
Disclaimer: The above news is based on official company disclosures and public announcements. Please consult your financial advisor before making any investment decisions.
